SLDB · Categories · Form 4

SLDB - SEC Form 4 insider transactions

Solid Biosciences Inc. (SLDB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for SLDB

• 50d
  SEC Form 4 filed by Tan Kevin

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 50d
  SEC Form 4 filed by Herzich Paul

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 50d
  SEC Form 4 filed by Brooks Gabriel

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 50d
  SEC Form 4 filed by Cumbo Alexander

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 50d
  SEC Form 4 filed by Howton David T

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 50d
  SEC Form 4 filed by Hanrahan Jessie

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 69d
  SEC Form 4 filed by Smith Ian F

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 91d
  SEC Form 4 filed by Director Perceptive Advisors Llc

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 112d
  President and CEO Cumbo Alexander converted options into 30,031 shares and sold $96,923 worth of shares (16,644 units at $5.82), increasing direct ownership by 6% to 235,405 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 112d
  Chief Regulatory Officer Hanrahan Jessie converted options into 8,125 shares and sold $24,074 worth of shares (4,134 units at $5.82), increasing direct ownership by 6% to 74,318 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 112d
  Director Ganot Ilan converted options into 4,861 shares and sold $15,478 worth of shares (2,658 units at $5.82) (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 112d
  Chief Technology Officer Herzich Paul converted options into 7,187 shares and sold $21,057 worth of shares (3,616 units at $5.82), increasing direct ownership by 5% to 72,638 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 112d
  Chief Operating Officer Howton David T converted options into 14,687 shares and sold $43,494 worth of shares (7,469 units at $5.82), increasing direct ownership by 7% to 105,077 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 112d
  Chief Medical Officer Brooks Gabriel converted options into 10,937 shares and sold 0 shares, increasing direct ownership by 6% to 89,466 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 112d
  CFO & Treasurer Tan Kevin converted options into 10,625 shares and sold $31,469 worth of shares (5,404 units at $5.82), increasing direct ownership by 6% to 99,422 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 124d
  Chief Operating Officer Howton David T sold $121,713 worth of shares (18,894 units at $6.44), decreasing direct ownership by 16% to 97,859 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 124d
  President and CEO Cumbo Alexander sold $315,093 worth of shares (48,913 units at $6.44), decreasing direct ownership by 18% to 222,018 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 124d
  Director Ganot Ilan sold $46,414 worth of shares (7,205 units at $6.44) (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 124d
  CFO & Treasurer Tan Kevin sold $95,231 worth of shares (14,783 units at $6.44), decreasing direct ownership by 14% to 94,201 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 124d
  Chief Medical Officer Brooks Gabriel sold $81,271 worth of shares (12,616 units at $6.44), decreasing direct ownership by 13% to 84,092 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 124d
  Chief Regulatory Officer Hanrahan Jessie sold $79,545 worth of shares (12,348 units at $6.44), decreasing direct ownership by 15% to 70,327 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 124d
  Chief Technology Officer Herzich Paul sold $70,249 worth of shares (10,905 units at $6.44), decreasing direct ownership by 14% to 69,067 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 128d
  CFO & Treasurer Tan Kevin converted options into 89,721 shares and sold $172,747 worth of shares (26,837 units at $6.44), increasing direct ownership by 136% to 108,984 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 128d
  President and CEO Cumbo Alexander converted options into 269,801 shares and sold $516,613 worth of shares (80,258 units at $6.44), increasing direct ownership by 233% to 270,931 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 128d
  Chief Regulatory Officer Hanrahan Jessie converted options into 82,550 shares and sold $170,803 worth of shares (26,535 units at $6.44), increasing direct ownership by 210% to 82,675 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 128d
  Chief Medical Officer Brooks Gabriel converted options into 87,072 shares and sold $182,390 worth of shares (28,335 units at $6.44), increasing direct ownership by 155% to 96,708 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 128d
  Chief Operating Officer Howton David T converted options into 121,616 shares and sold $243,128 worth of shares (37,771 units at $6.44), increasing direct ownership by 255% to 116,753 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 128d
  Chief Technology Officer Herzich Paul converted options into 79,600 shares and sold $168,969 worth of shares (26,250 units at $6.44), increasing direct ownership by 200% to 79,972 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 128d
  Director Ganot Ilan converted options into 15,000 shares (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 131d
  Director Ganot Ilan converted options into 4,273 shares and sold $1,259 worth of shares (191 units at $6.59) (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 148d
  CFO & Treasurer Tan Kevin converted options into 11,250 shares and sold $30,060 worth of shares (5,704 units at $5.27), increasing direct ownership by 14% to 46,100 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 154d
  Director Smith Ian F converted options into 4,573 shares, increasing direct ownership by 4% to 131,264 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 155d
  Director Ganot Ilan converted options into 2,994 shares and sold $5,718 worth of shares (1,053 units at $5.43) (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 188d
  Chief Operating Officer Howton David T converted options into 13,051 shares and sold $25,203 worth of shares (4,932 units at $5.11), increasing direct ownership by 33% to 32,908 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 188d
  President and CEO Cumbo Alexander converted options into 28,612 shares and sold $55,229 worth of shares (10,808 units at $5.11), increasing direct ownership by 28% to 81,388 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 188d
  Chief Regulatory Officer Hanrahan Jessie converted options into 11,862 shares and sold $22,908 worth of shares (4,483 units at $5.11), increasing direct ownership by 38% to 26,660 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 188d
  Chief Technology Officer Herzich Paul converted options into 7,239 shares and sold $13,802 worth of shares (2,701 units at $5.11), increasing direct ownership by 21% to 26,622 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 209d
  Director Ganot Ilan sold $13,505 worth of shares (3,278 units at $4.12), decreasing direct ownership by 3% to 95,412 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 232d
  Chief Medical Officer Brooks Gabriel converted options into 9,750 shares and sold $17,254 worth of shares (2,895 units at $5.96), increasing direct ownership by 25% to 33,819 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 246d
  Director Smith Ian F converted options into 4,573 shares, increasing direct ownership by 4% to 126,692 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 296d
  SEC Form 4 filed by Director Ganot Ilan

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 296d
  SEC Form 4 filed by Chief Operating Officer Howton David T

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 296d
  SEC Form 4 filed by CFO & Treasurer Tan Kevin

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 296d
  SEC Form 4 filed by Chief Technology Officer Herzich Paul

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 296d
  SEC Form 4 filed by Chief Medical Officer Brooks Gabriel

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 296d
  SEC Form 4 filed by Chief Regulatory Officer Hanrahan Jessie

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 296d
  SEC Form 4 filed by President and CEO Cumbo Alexander

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 337d
  Director Smith Ian F converted options into 4,573 shares, increasing direct ownership by 4% to 122,119 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 357d
  SEC Form 4 filed by Director Keresty Georgia

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Stone Adam Leo

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Perceptive Advisors Llc

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Smith Ian F

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Freed Martin I

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Nagendran Sukumar

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Ganot Ilan

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Kahn Clare

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 362d
  SEC Form 4 filed by Director Sullivan Lynne Marie

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 428d
  Director Smith Ian F converted options into 4,574 shares, increasing direct ownership by 4% to 117,546 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 474d
  SEC Form 4 filed by Large owner Ra Capital Management, L.P.

  4 - Solid Biosciences Inc. (0001707502) (Issuer)
• 477d
  Chief Regulatory Officer Hanrahan Jessie sold $12,193 worth of shares (3,079 units at $3.96) and converted options into 8,125 shares, increasing direct ownership by 35% to 19,281 units (SEC Form 4)

  4 - Solid Biosciences Inc. (0001707502) (Issuer)

Other SLDB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends